Details for New Drug Application (NDA): 017957
✉ Email this page to a colleague
NDA 017957 describes VEINAMINE 8%, which is a drug marketed by Hospira Inc and is included in one NDA. Additional details are available on the VEINAMINE 8% profile page.
The generic ingredient in VEINAMINE 8% is amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate profile page.
The generic ingredient in VEINAMINE 8% is amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate profile page.
Summary for 017957
| Tradename: | VEINAMINE 8% |
| Applicant: | Hospira Inc |
| Ingredient: | amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 8%;61MG/100ML;211MG/100ML;56MG/100ML;388MG/100ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 8.5% (8.5GM/100ML) | ||||
| Approval Date: | Aug 9, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 11.4% (11.4GM/100ML) | ||||
| Approval Date: | Aug 9, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
